Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Eszopiclone (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 26 Oct 2016 Status changed from recruiting to completed.
- 20 Jan 2009 New trial record.